FRANKFURT, Germany — The global economic rebound from the pandemic has picked up speed but remains uneven across countries and faces multiple headwinds. Most worrisome: the lack of vaccines in poorer nations, which could lead to new virus variants and more stop-and-go lockdowns.
Those were key points from the latest economic outlook published Monday by the Paris-based Organization for Economic Cooperation and Development.
OECD chief economist Laurence Boone said that economic prospects “have improved considerably in recent months, and the outlook is brightening … however, the health situation remains highly uncertain.”
The OECD said that relief and stimulus measures in the more developed world had done much to get the economy through the pandemic recession and back on the path of growth. It forecast global output would rise 5.8%, raising its forecast from 4.8% during its previous outlook in December. This year’s predicted rebound follows last year’s contraction of 3.5%, and would be the fastest since 1973.
Although the OECD said that most of the world would reach pre-pandemic levels of output by the end of 2022, it cautioned that “this is far from enough.”
It said that would still leave the global economy below the level it would have reached without the pandemic. The Paris-based organization listed several threats to the recovery, including lack of vaccines in poorer countries that have fewer resources for relief efforts. “A renewed virus-driven weakening of growth would be harder to cushion, resulting in further increases in acute poverty” and raising the risk of financial crisis, the OECD said in its forecast report.
“This is all the more troubling because, notwithstanding the impact on lives and livelihoods, the global economic and social cost of maintaining closed borders dwarfs the costs of making vaccines, tests and health supplies more widely available to these countries.”
As long as the vast majority of the global population is not vaccinated, the report said, “all of us remain vulnerable to the emergence of new variants.”
Source: Read Full Article